TME Subtype Classification on TCGA Pan-cancer
94.5ROCAUCSNN
Evaluation Results
| Method | Links | ||||
|---|---|---|---|---|---|
| SNN2024.06 | 94.5 | 85.1 | 80 | 77 | |
| PathoTMETraining=1 stage2024.06 | 69.5 | 42.8 | 46.6 | 39.7 | |
| Siamese+DANNContext=Ablation study2024.06 | 68.7 | 42.1 | 46.3 | 39.6 | |
| PathoTMETraining=2 stages2024.06 | 67.9 | 41.4 | 46.2 | 39.7 | |
| DANNContext=Ablation study2024.06 | 67.3 | 41.3 | 44.6 | 39.2 | |
| SiameseContext=Ablation study2024.06 | 66.1 | 38.8 | 45.2 | 35.7 | |
| Visual promptsContext=Ablation study2024.06 | 65.8 | 38.5 | 43.8 | 34.1 | |
| SupCont2024.06 | 64.4 | 37.8 | 43.6 | 34.1 | |
| CLAM2024.06 | 63.9 | 36.9 | 42.5 | 35.3 | |
| ABMIL2024.06 | 63.5 | 36.5 | 42.1 | 35.7 | |
| TransMIL2024.06 | 63 | 36.5 | 41.5 | 31.3 | |
| ABMIL-gated2024.06 | 62.9 | 36.3 | 41.6 | 35.2 | |
| DSMIL2024.06 | 61.6 | 35 | 42.5 | 32.4 | |
| KNN2024.06 | 60.3 | 33 | 38.4 | 34.3 |